Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
WQ Gan, SFP Man, A Senthilselvan, DD Sin - Thorax, 2004 - thorax.bmj.com
Background: Individuals with chronic obstructive pulmonary disease (COPD) are at
increased risk of cardiovascular diseases, osteoporosis, and muscle wasting. Systemic …
increased risk of cardiovascular diseases, osteoporosis, and muscle wasting. Systemic …
Surfactant protein D in respiratory and non-respiratory diseases
GL Sorensen - Frontiers in medicine, 2018 - frontiersin.org
Surfactant protein D (SP-D) is a multimeric collectin that is involved in innate immune
defense and expressed in pulmonary, as well as non-pulmonary, epithelia. SP-D exerts …
defense and expressed in pulmonary, as well as non-pulmonary, epithelia. SP-D exerts …
Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease
Rationale: Patients with chronic obstructive pulmonary disease (COPD) are afflicted by
comorbidities. Few studies have prospectively evaluated COPD comorbidities and mortality …
comorbidities. Few studies have prospectively evaluated COPD comorbidities and mortality …
[HTML][HTML] Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort
J Miller, LD Edwards, A Agustí, P Bakke… - Respiratory …, 2013 - Elsevier
Comorbidities, are common in COPD, have been associated with poor outcomes and are
thought to relate to systemic inflammation. To investigate comorbidities in relation to …
thought to relate to systemic inflammation. To investigate comorbidities in relation to …
UK health performance: findings of the Global Burden of Disease Study 2010
Background The UK has had universal free health care and public health programmes for
more than six decades. Several policy initiatives and structural reforms of the health system …
more than six decades. Several policy initiatives and structural reforms of the health system …
Epidemiology of chronic obstructive pulmonary disease: a literature review
CE Rycroft, A Heyes, L Lanza… - International journal of …, 2012 - Taylor & Francis
The aim of this study is to quantify the burden of chronic obstructive pulmonary disease
(COPD)–incidence, prevalence, and mortality–and identify trends in Australia, Canada …
(COPD)–incidence, prevalence, and mortality–and identify trends in Australia, Canada …
Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care
JR Feary, LC Rodrigues, CJ Smith, RB Hubbard… - Thorax, 2010 - thorax.bmj.com
Background Comorbidities associated with systemic inflammation including cardiovascular
disease (CVD), stroke and diabetes mellitus (DM) are common among individuals with …
disease (CVD), stroke and diabetes mellitus (DM) are common among individuals with …
[HTML][HTML] COPD surveillance—United States, 1999-2011
ES Ford, JB Croft, DM Mannino, AG Wheaton, X Zhang… - Chest, 2013 - Elsevier
This report updates surveillance results for COPD in the United States. For 1999 to 2011,
data from national data systems for adults aged≥ 25 years were analyzed. In 2011, 6.5% of …
data from national data systems for adults aged≥ 25 years were analyzed. In 2011, 6.5% of …
Outcomes for COPD pharmacological trials: from lung function to biomarkers
M Cazzola, W MacNee, FJ Martinez… - European …, 2008 - publications.ersnet.org
The American Thoracic Society/European Respiratory Society jointly created a Task Force
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …